Preview
Management of dysrhythmias, particularly asymptomatic dysrhythmias, continues to be a vexing clinical problem. In which patients, if any, is treatment warranted? What benefit is provided by treatment? If treatment is indicated, which drug should be used? How should treatment be monitored and what therapeutic end point should be used? Drs Lofgren and Hoppe address these and other questions in their article on what one reviewer called a “most timely” subject.